ARTICLES | ONLINE FIRST Inhaled isoflurane via the anaesthetic conserving device versus propofol for sedation of invasively ventilated patients in intensive care units in Germany and Slovenia: an open-label, phase 3, randomised controlled, non-inferiority trial Andreas Meiser, Thomas Volk, Jan Wallenborn, et al Lancet Respir Med Published:August 26, 2021 DOI:https://doi.org/10.1016/S2213-2600(21)00323-4 Summary Background Previous studies indicate tha...

Association of Volume of Sepsis Cases and Mortality Sepsis is a leading cause of death worldwide and is also associated with a high burden of patient mortality.  This burden is expected to increase as populations age. Patients with sepsis typically require high-cost interventions in ICUs. Even with urgent treatment, the probability of death still remains high. However, ICUs that have more experience treating such patients may be associated with lower mortality...

ARTICLES|ONLINE FIRST Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial Bernadette C Young, David W Eyre, Saroj Kendrick, et al Lancet Published:September 14, 2021 DOI:https://doi.org/10.1016/S0140-6736(21)01908-5 Summary Background School-based COVID-19 contacts in England have been asked to self-isolate at home...

Original Investigation September 21, 2021 Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients: A Randomized Clinical Trial Jennie Johnstone, Maureen Meade, François Lauzier, et al JAMA. 2021;326(11):1024-1033. doi:10.1001/jama.2021.13355 Abstract Importance  Growing interest in microbial dysbiosis during critical illness has raised questions about the therapeutic potential of microbiome modifi...

Safe Liberation During Weaning from VV-ECMO The use of venovenous extracorporeal membrane oxygenation (VV-ECMO) in patients with severe acute respiratory distress syndrome (ARDS) has increased substantially over the last few years. However, conclusive evidence supporting its use is still lacking, and mortality of patients treated with VV-ECMO for ARDS is still high. Optimal strategies of mechanical ventilation (MV) during VV-ECMO have been reported, but there is...

ONLINE FIRST (FREE ACCESS) OriginalsManagement of arterial partial pressure of carbon dioxide in the first week after traumatic brain injury: results from the CENTER-TBI studyCiterio G. et al.Occurrence and timing of withdrawal of life-sustaining measures in traumatic brain injury patients: a CENTER-TBI studyvan Veen E. et al. Correspondances“L’histoire se répète”, one size does not fit allKuindersma M. and Spronk P.E.“L'histoire se répète”, one size does not fi...

Intubation Timing and COVID-19 ARDS Outcomes COVID-19 associated ARDS is associated with high mortality risk. Many patients with COVID-19 have been admitted with pneumonia and arterial hypoxaemia, increased work of breathing or impending fatigue. It is a common clinical practice to intubate patients with severe hypoxaemia. However, during the pandemic, there was a high demand for ICU beds. Therefore, some experts recommended a more conservative approach and promote...

ORIGINAL ARTICLE Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel Yinon M. Bar-On, Yair Goldberg, Micha Mandel, et al N Engl J Med September 15, 2021DOI: 10.1056/NEJMoa2114255 Abstract BACKGROUND On July 30, 2021, the administration of a third (booster) dose of the BNT162b2 messenger RNA vaccine (Pfizer–BioNTech) was approved in Israel for persons who were 60 years of age or older and who had received a second dose of vaccine at lea...

Prone Positioning and Survival in Mechanically Ventilated COVID-19 Patients Coronavirus disease is still fairly new for clinicians who are constantly searching for therapies for patients with respiratory failure from COVID-19. Early implementation of prone positioning ventilation has been shown to improve survival in patients with ARDS. However, data on the effect of probing on survival in patients with COVID-19 is still scarce. The American Thoracic Society, Eu...

ARTICLES| VOLUME 398, ISSUE 10302, P747-758, AUGUST 28, 2021 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study Lixue Huang, Qun Yao, Xiaoying Gu, et al Lancet 2021; 398: 747-758 Summary Background The full range of long-term health consequences of COVID-19 in patients who are discharged from hospital is largely unclear. The aim of our study was to comprehensively compare consequences between 6 months and 12 m...